Critical Care Obstetrics part 11 pps

10 344 0
Critical Care Obstetrics part 11 pps

Đang tải... (xem toàn văn)

Thông tin tài liệu

Fluid and Electrolyte Balance 89 109 Lorenz W , Doenicke A , Freund M et al. Plasma histamine levels in man following infusion of hydroxyethyl starch: a contribution to the question of allergic or anaphylactoid reactions following administration of a new plasma substitute . Anaesthesist 1975 : 24 : 228 – 230 . 110 Maurer PH , Berardinelli B . Immunologic studies with hydroxyethyl starch (HES): a proposed plasma expander . Transfusion 1968 ; 8 : 265 – 268 . 111 Ring J , Seifert B , Messmer K et al. Anaphylactoid reactions due to hydroxyethyl starch infusion . Eur Surg Res 1976 ; 8 : 389 – 399 . 112 Muller N , Popov - Cenic S , Kladetzky RG et al. The effect of hydroxy- ethyl starch on the intra - and postoperative behavior of haemostasis . Bibl Anat 1977 ; 16 : 460 – 462 . 113 Solanke TF . Clinical trial of 6% hydroxyethyl starch (a new plasma expander) . Br Med J 1968 ; 3 : 783 – 785 . 114 Weatherbee L , Spencer HH , Knopp CT et al. Coagulation studies after the transfusion of hydroxyethyl starch protected frozen blood in primates . Transfusion 1974 ; 14 : 109 – 115 . 115 Strauss RG , Stump DC , Henriksen RA . Hydroxyethyl starch accentuates von Willebrand ’ s disease . Transfusion 1985 ; 25 : 235 – 237 . 116 Mattox KL , Maningas PA , Moore EE et al. Prehospital hypertonic saline/dextran infusion for post - traumatic hypotension . Ann Surg 1991 ; 213 : 482 – 491 . 117 Chang JC , Gross HM , Jang NS . Disseminated intravascular coagula- tion due to intravenous administration of hetastarch . Am J Med Sci 1990 ; 300 : 301 – 303 . 118 Cully MD , Larson CP , Silverberg GD . Hetastarch coagulopathy in a neurosurgical patient . Anesthesiology 1987 ; 66 : 706 – 707 . 119 Damon L , Adams M , Striker RB et al. Intracranial bleeding during treatment with hydroxyethyl starch . N Engl J Med 1987 ; 317 : 964 – 965 . 120 Ali F , Guglin M , Vaitkevicius P . Theraputic potential of vasopressin receptor antagonists . Drug 2007 ; 67 ( 6 ): 847 – 858 . 121 Guyton AC , Hall JE . Regulation of extracellular fl uid, osmolarity and sodium concentration . In: Guiton AC , Hall JE , eds. Textbook of Medical Physiology , 9th edn . Philadelphia, Pennsylvania : WB Saunders Company , 1996 : 349 – 365 . 122 Lindheimer MD , Davison JM . Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy . Eur J Endocrinol 1995 ; 132 ( 2 ): 133 – 143 . 123 Anderson RJ , Chung H - M , Kluge R , Schrier RW . Hyponatremia: a prospective analysis of its epidemiology and pathogenetic role of vasopressin . Ann Intern Med 1985 ; 102 : 164 – 168 . 124 Thomsen JK , Fogh - Andersen N , Jaszczak P . Atrial natriuretic peptide, blood volume, aldosterone, and sodium excretion during twin pregnancy . Acta Obstet Gynecol Scand 1994 ; 73 : 14 – 20 . 125 Weisberg LS . Pseudohyponatremia: a reappraisal . Am J Med 1989 ; 86 : 315 – 318 . 126 Abdul - Karim R , Assali NS . Renal function in human pregnancy, V Effects of oxytocin on renal hemodynamics and water electrolyte excretion . J Lab Clin Med 1961 ; 57 : 522 – 532 . 127 Chesley LC . Management of preeclampsia and eclampsia . In: Chesley LC , ed. Hypertensive Disorders in Pregnancy . New York : Appleton - Century - Crofts , 1978 : 345 . 128 Josey WE , Pinto AP , Plante RF . Oxytocin induced water intoxica- tion . Am J Obstet Gynecol 1969 ; 104 : 926 . 129 Morgan DB , Kirwan NA , Hancock KW et al. Water intoxication and oxytocin infusion . Br J Obstet Gynaecol 1977 ; 84 : 6 – 12 . 89 Mishler JM , Ricketts CR , Parkhouse EJ . Post transfusion survival of hydroxyethyl starch 450/0.7 in man: a long term study . J Clin Pathol 1980 ; 33 : 155 – 159 . 90 Mishler JM , Borberg H , Emerson PM . Hydroxyethyl starch, an agent for hypovolemic shock treatment. II. Urinary excretion in normal volunteers following three consecutive daily infusions . Br J Pharmacol 1977 ; 4 : 591 – 595 . 91 Puri VK , Paidipaty B , White L . Hydroxyethyl starch for resuscitation of patients with hypovolemia in shock . Crit Care Med 1981 ; 9 : 833 – 837 . 92 Ring J , Messmer K . Incidence and severity of anaphylactoid reac- tions to colloid volume substitutes . Lancet 1977 ; 1 : 466 – 469 . 93 Bogan RK , Gale GR , Walton RP . Fate of 14C - label hydroxyethyl starch in animals . Toxicol Appl Pharmacol 1969 ; 15 : 206 – 211 . 94 Metcalf W , Papadopoulos A , Tufaro R et al. A clinical physiologic study of hydroxyethyl starch . Surg Gynecol Obstet 1970 ; 131 : 255 – 267 . 95 Thompson WL , Fukushima T , Rutherford RB et al. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch . Surg Gynecol Obstet 1970 ; 131 : 965 – 972 . 96 Mishler JM , Ricketts CR , Parkhouse EJ . Changes in molecular com- position of circulating hydroxyethyl starch following consecutive daily infusions in man . Br J Clin Pharmacol 1979 ; 7 : 505 – 509 . 97 Hofer RE , Lanier WL . Effect of hydroxyethyl starch solutions on blood glucose concentrations in diabetic and nondiabetic rats . Crit Care Med 1992 ; 20 : 211 – 215 . 98 Ballinger WF . Preliminary report on the use of hydroxyethyl starch solution in man . J Surg Res 1966 ; 6 : 180 – 183 . 99 Kilian J , Spilker D , Borst R . Effect of 6% hydroxyethyl starch, 45% dextran 60 and 5.5% oxypolygelatine on blood volume and circula- tion in human volunteers . Anaesthesist 1975 ; 24 : 193 – 197 (in German). 100 Lee WH , Cooper N , Weidner MG . Clinical evaluation of a new plasma expander: hydroxyethyl starch . J Trauma 1968 ; 8 : 381 – 393 . 101 Khosropour R , Lackner F , Steinbereithner K et al. Comparison of the effect of pre - and intraoperative administration of medium molecular weight hydroxyethyl starch (HES 200/0.5) and dextran 40 (60) in vascular surgery . Anaesthesist 1980 ; 29 : 616 – 622 (in German). 102 Laks H , Pilon RN , Anderson W et al. Acute normovolemic hemo- dilution with crystalloid vs colloid replacement . Surg Forum 1974 ; 25 : 21 – 22 . 103 Diehl JT , Lester JL 3rd , Cosgrove DM . Clinical comparison of het- astarch and albumin in postoperative cardiac patients . Ann Thorac Surg 1982 ; 34 : 674 – 679 . 104 Shatney CH , Deapiha K , Militello PR et al. Effi cacy of hetastarch in the resuscitation of patients with multisystem trauma and shock . Arch Surg 1983 ; 118 : 804 – 809 . 105 Kirklin JK , Lell WA , Kouchoukos NT . Hydroxyethyl starch vs albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization . Ann Thorac Surg 1984 ; 37 : 40 – 46 . 106 Boon JC , Jesch F , Ring J et al. Intravascular persistence of hydroxy- ethyl starch in man . Eur Surg Res 1976 ; 8 : 497 – 503 . 107 Kohler H , Kirch W , Horstmann HJ . Hydroxyethyl starch - induced macroamylasemia . Int J Clin Pharmacol Biopharm 1977 ; 15 : 428 – 431 . 108 Korttila K , Grohn P , Gordin A et al. Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagula- tion . J Clin Pharmacol 1984 ; 24 : 273 – 282 . Chapter 6 90 152 Oh MS , Carroll HJ . Hypernatremia . In: Hurst JW , ed. Medicine for the Practicing Physician , 3rd edn . Boston : Butterworth - Heinemann , 1992 : 1293 . 153 Ananthakrishnan S. Diabetes insipidus in pregnancy: etiology, eval- uation, and management . Endocr Pract 2009 ; 15 ( 4 ): 377 – 382 . 154 Sjoholm I , Ymam L . Degradation of oxytocin lysine – vasopressin, angiotensin II, angiotensin II - amide by oxytocinase . Acta Pharmacol Suecca 1967 ; 4 : 65 – 76 . 155 Krege J , Katz VL , Bowes WA Jr . Transient diabetes insipidus of pregnancy . Obstet Gynecol Surv 1989 ; 44 ( 11 ): 789 – 795 . 156 Williams DJ , Metcalf KA , Skingle AI . Pathophysiology of transient cranial diabetes insipidus during pregnancy . Clin Endocrinol (Oxf) 1993 ; 38 : 595 – 600 . 157 Tur - Kasm I , Paz I , Gleicher W . Disorders of the pituitary and hypo- thalamus . In: Gleicher N , Butino L et al., eds. Principles and Practice of Medical Therapy in Pregnancy , 3rd edn . Stamford, Connecticut : Appleton & Lange , 1998 : 424 – 430 . 158 Ross EJ , Christie SB . Hypernatremia . Medicine 1969 ; 48 : 441 – 473 . 159 Arieff AI , Guisado R . Effects on the central nervous system of hypernatremic and hyponatremic states . Kidney Int 1976 ; 10 : 104 – 116 . 160 Miller M , Dalakos T , Moses AM et al. Recognition of partial defects in antidiuretic hormone secretion . Ann Intern Med 1970 ; 73 : 721 – 729 . 161 Blum D , Brasseur D , Kahn A , Brachet E . Safe oral rehydration of hypertonic dehydration . J Pediatr Gastroenterol Nutr 1986 ; 5 : 232 – 235 . 162 Bode HH , Harley BM , Crawford JD . Restoration of normal drinking behavior by chlorpropamide in patients with hypodipsia and diabe- tes insipidus . Am J Med 1971 ; 51 : 304 – 313 . 163 Lindeheimer MD , Richardson DA , Ehrlich EN . Potassium homeo- stasis in pregnancy . J Reprod Med 1987 ; 32 ( 7 ): 517 – 532 . 164 Godfrey BE , Wadsworth GR . Total body potassium in pregnant women . J Obstet Gynaecol Br Cmwlth 1970 ; 77 : 244 – 246 . 165 Anotayanouth S , Subhedar NV , Garner P et al. Betamimetics for inhibiting preterm labor . Cochrane Database Syst Rev 2004 ; Oct 18 ( 4 ): CD004325. 166 Braden GL , von Oeyen PT , Germain MJ . Ritodrine and terbutaline - induced hypokalemia in preterm labor: Mechanisms and conse- quences . Kidney Int 1997 ; 51 : 1867 – 1875 . 167 Cano A , Tovar I , Parrilla JJ et al. Metabolic disturbances during intravenous use of ritodrine: Increased insulin levels and hypokale- mia . Obstet Gynecol 1985 ; 65 : 356 – 360 . 168 Hildebrandt R , Weitzel HK , Gundert - Remy U . Hypokalemia in pregnant women treated with β 2 mimetic drug fenoterol – A concen- tration and time dependent effect . J Perinat Med 1997 ; 25 ( 2 ): 173 – 179 . 169 O ’ Sullivan E , Monga M , Graves W . Bartter ’ s syndrome in pregnancy – a case report and review . Am J Perinatol 1997 ; 14 ( 1 ): 55 – 57 . 170 Johnson JR , Miller RS , Samuels P . Bartter syndrome in pregnancy . Obstet Gynecol 2000 ; 95 ( 6 Part 2 ): 1035 . 171 Nohira T , Nakada T , Akutagawa O et al. Pregnancy complicated with Bartter ’ s syndrome: A case report . J Obstet Gynaecol Res 2001 ; 27 ( 5 ): 267 – 274 . 172 Smulian JC , Motiwala S , Sigman RC . Pica in a rural obstetric popula- tion . South Med J 1995 ; 88 : 1236 – 1240 . 173 Ukaonu C , Hill DA , Christensen F . Hypokalemic myopathy in preg- nancy caused by clay ingestion . Obstet Gynecol 2003 ; 102 ( 5 pt 2 ): 1169 – 1171 . 130 Wang JY , Shih HL , Yuh FL et al. An unforgotten cause of acute hyponatremia: water intoxication due to oxytocin administration in a pregnant woman . Nephron 2000 ; 86 : 342 – 343 . 131 Moen V , Brundin L , Rundgren M et al. Hyponatremia complicated labor – rare or unrecognized? A prospective observational study . BJOG 2009 ; 116 ( 4 ): 552 – 561 . 132 Ruchala PL , Metheny N , Essenpreis H et. al. Current practice in oxytocin dilution and fl uid administration for induction of labor . J Obstet Gynecol Neonatal Nurs 2002 ; 31 ( 5 ): 545 – 550 . 133 Theunissen IM , Parer JT . Fluids and electrolytes in pregnancy . Clin Obstet Gynecol 1994 ; 34 ( 1 ): 3 – 15 . 134 Burneo J , Vizcarra D , Miranda H , Central pontine myelinolysis and pregnancy. A case report and review of the literature . Rev Neurol 2000 ; 30 ( 11 ): 1036 – 1040 . 135 Sandhu G , Ramaiyah S , Chan C , et al. Pathophysiology and manage- ment of preeclampsia - associated severe hyponatremia . Am J Kidney Dis 2010 ; 55 ( 3 ): 599 – 603 . 136 Boulanger E , Pagniez D , Roueff S , Sheehan syndrome presenting as early postpartum hyponatremia . Nephrol Dial Transplant 1999 ; 14 ( 11 ): 2714 – 2715 . 137 Pollock AS , Arieff AL . Abnormalities of cell volume regulation and their functional consequences . Am J Physiol 1980 ; 239 : F195 – 205 . 138 Arieff AI . Hyponatremia, convulsions, respiratory arrest, and per- manent brain damage after elective surgery in healthy women . N Engl J Med 1986 ; 314 : 1529 – 1535 . 139 Decaux G , Genette F , Mockel J . Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone . Ann Intern Med 1980 ; 93 : 716 – 717 . 140 Beck LH . Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone . N Engl J Med 1979 ; 301 : 528 – 530 . 141 Biwas M , Davies JS . Hyponatremia in clinical practice . Postgraduate Med J 2007 ; 83 : 373 – 378 . 142 Sterns RH . The treatment of hyponatremia: fi rst, do no harm . Am J Med 1990 ; 88 : 557 – 560 . 143 Soupart A , Penninckx R , Stenuit A et al. Treatment of chronic hypo- natremia in rats by intravenous saline: comparison of rate versus magnitude of correction . Kidney Int 1992 ; 41 : 1662 – 1667 . 144 Kamel KS , Bear RA . Treatment of hyponatremia: a quantitative analysis . Am J Kidney Dis 1993 ; 21 : 439 – 443 . 145 Hantman D , Rossier B , Zohlman R et al. Rapid correction of hypo- natremia in the syndrome of appropriate secretion of antidiuretic hormone . Ann Intern Med 1973 ; 78 : 870 – 875 . 146 Packer M , Medina N , Yushnak M . Correction of dilutional hypona- tremia in severe chronic heart failure by converting - enzyme inhibi- tion . Ann Intern Med 1984 ; 100 : 782 – 789 . 147 Berl T . Mannitol a therapeutic alternative in the treatment of acute hyponatremia . Crit Care Med 2000 ; 28 ( 6 ): 2152 – 2153 . 148 Porzio P , Halberthal M , Bohn D et al. Treatment of acute hyponatremia: Ensuring the excretion of a predictable amount of electrolyte - free water . Crit Care Med 2000 ; 28 ( 6 ): 1905 – 1910 . 149 Hussar D , New drugs 07, part 1 . Nursing 2007 ; 37 ( 2 ): 51 – 58 . 150 Zeltser D , Rosansky S , Verbalis JG et al. Assessment of the effi cacy and safety of intravenous conivaptan in euvolemic and hypervol- emic hyponatremia . Am J Nephrol 2007 ; 27 ( 5 ); 447 – 457 . 151 Steinwall M , BossmarT , BrouardR , The effect of reclovaptan (sR49059) , an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labor . Gynecol Endocrinol 2005 ; 20 ( 2 ): 104 – 109 . Fluid and Electrolyte Balance 91 196 Carney SL , Wong NL , Quamme GA et al. Effect of magnesium defi ciency on renal magnesium and calcium transport in the rat . J Clin Invest 1980 ; 65 : 180 – 188 . 197 Snyder SW , Cardwill MS . Neuromuscular blockade with magnesium sulfate and nifedipine . Am J Obstet Gynecol 1989 ; 161 ( 1 ): 35 – 36 . 198 Kurtzman JL , Thorp JM Jr , Spielman FJ , Mueller RC , Cerfalo RC . Do nifedipine and verapamil potentiate the cardiac toxicity of mag- nesium sulfate? Am J Perinatol 1993 ; 10 ( 6 ): 450 – 452 . 199 Magee LA , Miremadi S , Li J et al. Therapy with both magnesium and nifedipine does not increase the risk of serious magnesium - related maternal side effects in women with preeclampsia . Am J Obstet Gynecol 2005 ; 1 : 153 – 163 . 200 Anast CS , Winnacker JL , Forte LR , Burns TW . Impaired release of parathyroid hormone in magnesium defi ciency . J Clin Endocrinol Metab 1976 ; 42 : 707 – 717 . 201 Zaloga GP , Wilkens R , Tourville J et al. A simple method for determining physiologically active calcium and magnesium concentrations in critically ill patients . Crit Care Med 1987 ; 15 : 813 – 816 . 202 Zaloga GP , Chernow B . The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone - vitamin D axis . Ann Intern Med 1987 ; 107 : 36 – 41 . 203 Zaloga GP , Chernow B . Stress - induced changes in calcium metabo- lism . Semin Respir Med 1985 ; 7 : 56 . 204 Chernow B , Rainey TG , Georges LP , O ’ Brian JT . Iatrogenic hyper- phosphatemia: a metabolic consideration in critical care medicine . Crit Care Med 1981 ; 9 : 772 – 774 . 205 Zaloga GP . Phosphate disorders . Probl Crit Care 1990 ; 4 : 416 . 206 Nagant De Deuxchaisnes C , Krane SM . Hypoparathyroidism . In: Avioli LV , Krane SM , eds. Metabolic Bone Disease , vol 2 . Orlando, FL : Academic , 1978 : 217 . 207 Zaloga GP , Chernow B . Calcium metabolism . Clin Crit Care Med 1985 ; 5 . 208 Monif GR , Savory J . Iatrogenic maternal hypocalcemia following magnesium sulfate therapy . JAMA 1972 ; 219 ( 11 ): 1469 – 1470 . 209 Haynes RC , Murad F . Agents affecting calcifi cation: calcium, para- thyroid hormone, calcitonin, vitamin D, and other compounds . In: Gilman AG , Goodman LS , Rall TW , Murad F , eds. Goodman and Gilman ’ s The Pharmacological Basis of Therapeutics . N e w Yo r k : Macmillan , 1985 : 1517 . 210 Ennen CS , Magann EF . Milk alkali syndrome presenting as acute renal insuffi ciency during pregnancy . Obstet Gynecol 2006 ; 108 ( 3 pt 2 ): 785 – 786 . 211 Benabe JE , Martinez - Maldonado R . Disorders of calcium metabo- lism . In: Maxwell MH , Kleeman CR , Narins RG , eds. Clinical Disorders of Fluid and Electrolyte Metabolism , 4th edn . New York : McGraw - Hill , 1987 : 758 . 212 Mundy GR . Calcium Homeostasis: Hypercalcemia and Hypocalcemia . London : Martin Dunitz , 1989 : 1 . 213 Montoro MN , Paler RJ , Goodwin TM et al. Parathyroid carcinoma during pregnancy . Obstet Gynecol 2000 ; 96 ( 5 Part 2 ): 841 . 214 Mestamen JH . Parathyroid disorders of pregnancy . Semin Perinatol 1998 ; 22 ( 6 ): 485 – 496 . 215 Thomas AK , McVie R , Levine SN . Disorders of maternal calcium metabolism implicated by abnormal calcium metabolism in the neonate . Am J Perinatol 1999 ; 16 ( 10 ): 515 – 520 . 216 Illidge TM , Hussey M , Godden CW . Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidro- nate . Clin Oncol (R Coll Radiol) 1996 ; 8 ( 4 ): 257 – 258 . 174 Flakeb G , Villarread D , Chapman D . Is hypokalemia a cause of ventricular arrhythmias? J Crit Ill 1986 ; 1 : 66 . 175 Marino P . Potassium . In: Marino P , ed. The ICU Book . Philadelphia : Lea & Febiger , 1991 : 478 . 176 Smith JD , Bia MJ , DeFronzo RA . Clinical disorders of potassium metabolism . In: Arieff AI , DeFronzo RA , eds. Fluid, Electrolyte and Acid – Base Disorders . New York : Churchill Livingstone , 1985 : 413 . 177 Hartman RC , Auditore JC , Jackson DP . Studies in thrombocytosis. I. Hyperkalemia due to release of potassium from platelets during coagulation . J Clin Invest 1958 ; 37 : 699 . 178 Robertson GL . Abnormalities of thirst regulation . Kidney Int 1984 ; 25 : 460 – 469 . 179 Oster JR , Perez GO , Vaamonde CA . Relationship between blood pH and phosphorus during acute metabolic acidosis . Am J Physiol 1978 ; 235 : F345 – 351 . 180 Bismuth C , Gaultier M , Conso F et al. Hyperkalemia in acute digi- talis poisoning: prognostic signifi cance and therapeutic implica- tions . Clin Toxicol 1973 ; 6 : 153 – 162 . 181 Williams ME , Rosa RM . Hyperkalemia: disorders of internal and external potassium balance . J Intensive Care Med 1988 ; 3 : 52 . 182 Phelps KR , Lieberman RL , Oh MS et al. Pathophysiology of the syndrome of hyporeninemic hypoaldosteronism . Metabolism 1980 ; 29 : 186 – 199 . 183 Sato K , Nishiwaki K , Kuno N et al. Unexpected hyperkalemia fol- lowing succinylcholine administration in prolonged immobilized parturients treated with magnesium and ritodrine . Anesthesiology 2000 ; 93 ( 6 ): 1539 – 1541 . 184 Spital A , Greenwell R . Severe hyperkalemia during magnesium sulfate therapy in two pregnant drug abusers . South Med J 1991 ; 84 ( 7 ): 919 – 921 . 185 Villabona C , Rodriguez P , Joven J . Potassium disturbances as a cause of metabolic neuromyopathy . Intensive Care Med 1987 ; 13 : 208 – 210 . 186 Allon M , Shanklin N . Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol . Am J Kidney Dis 1996 ; 28 ( 4 ): 508 – 514 . 187 Greenberg A . Hyperkalemia treatment options . Semin Nephrol 1998 ; 18 ( 1 ): 46 – 57 . 188 Mandelberg A , Krupnik Z , Houri S et al. Salbutamol metered - dose inhaler with spacer for hyperkalemia: how fast? How safe? Chest 1999 ; 115 ( 3 ): 617 – 622 . 189 Stems Rh , Rojas M , Bernstein P , et al. Ion exchange resinsfor the treatment of hyperkalemia: Are they safe and effective? J Soc Nephrol 2010 : [Epup ahead of print]. 190 Marino P . Calcium and phosphorus . In: Marino P , ed. The ICU Book . Philadelphia : Lea & Febiger , 1991 : 499 . 191 ACOG Technical Bulletin No. 219, January 1996 : 518 . 192 Cruikshank DP , Pitkin RM , Reynolds WA et al. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I – Maternal and fetal responses . Am J Obstet Gynecol 1979 ; 134 : 243 – 249 . 193 Cruikshank DP , Chan GM , Doerrfeld D . Alterations in vitamin D and calcium metabolism with magnesium sulfate treatment of pre- eclampsia . Am J Obstet Gynecol 1993 ; 168 : 1170 – 1177 . 194 Cruikshank DP , Pitkin RM , Donnelly E et al. Urinary magnesium, calcium and phosphate excretion during magnesium sulfate infu- sion . Obstet Gynecol 1981 ; 58 : 430 – 434 . 195 Cholst IN , Steinberg SF , Tropper PJ et al. The infl uence of hyper- magnesemia on serum calcium and parathyroid hormone levels in human subjects . N Engl J Med 1984 ; 310 : 1221 – 1225 . Chapter 6 92 231 Iseri LT , Freed J , Bures AR . Magnesium defi ciency and cardiac dis- orders . Am J Med 1975 ; 58 : 837 – 846 . 232 Burch GE , Giles TD . The importance of magnesium defi ciency in cardiovascular disease . Am Heart J 1977 ; 94 : 649 – 651 . 233 Rasmussen HS , McNair P , Norregard P et al. Intravenous magnesium in acute myocardial infarction . Lancet 1986 ; 1 : 234 – 236 . 234 Abraham AS , Rosenmann D , Kramer M et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction . Arch Intern Med 1987 ; 147 : 753 – 755 . 235 Flink EB . Therapy of magnesium defi ciency . Ann NY Acad Sci 1969 ; 162 : 901 – 905 . 236 Mordes JP , Wacker WE . Excess magnesium . Pharmacol Rev 1977 ; 29 : 273 – 300 . 237 Heath DA . The emergency management of disorders of calcium and magnesium . Clin Endocrinol Metab 1980 ; 9 : 487 – 502 . 238 Rude RK , Singer FR . Magnesium defi ciency and excess . Annu Rev Med 1981 ; 32 : 245 – 259 . 239 Cronin RE , Knochel JP . Magnesium defi ciency . Adv Intern Med 1983 ; 28 : 509 – 533 . 240 Whang R , Flink EB , Dyckner T et al. Magnesium depletion as a cause of refractory potassium repletion . Arch Intern Med 1985 ; 145 : 1686 – 1689 . 241 Stewart AF , Horst R , Deftos LJ et al. Biochemical evaluation of patients with cancer - associated hypercalcemia: evidence for humoral and nonhumoral groups . N Engl J Med 1980 ; 303 : 1377 – 1383 . 242 Waisman GD , Mayorga LM , Camera MI , Vignolo CA , Martinotti A . Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988 ; 159 ( 2 ): 308 – 309 . 243 Fassler CA , Rodriguez RM , Badesch DB et al. Magnesium toxicity as a cause of hypotension and hypoventilation . Arch Intern Med 1985 ; 14 : 1604 – 1606 . 244 Bohman VR , Cotton DB . Supralethal magnesemia with patient sur- vival . Obstet Gynecol 1990 ; 76 : 984 – 985 . 245 Oh MS . Selective hypoaldosteronism . Resident Staff Phys 1982 ; 28 : 46S . 217 Graepel P , Bentley P , Fritz H et al. Reproductive studies with pami- dronate . Arzneimittelforschung 1992 ; 42 ( 5 ): 654 – 667 . 218 Quamme GA , Dirks KJ . Magnesium metabolism . In: Maxwell MH , Kleeman CR , Narins RG , eds. Clinical Disorders of Fluid and Electrolyte Metabolism , 4th edn . New York : McGraw - Hill 1987 : 297 . 219 Zaloga GP , Roberts JE . Magnesium disorders . Probl Crit Care 1990 ; 4 : 425 . 220 Salem M , Munoz R , Chernow B . Hypomagnesemia in critical illness. A common and clinically important problem . Crit Care Clin 1991 ; 7 : 225 – 252 . 221 Reinhart RA . Magnesium metabolism. A review with special refer- ence to the relationship between intracellular content and serum levels . Arch Intern Med 1988 ; 148 : 2415 – 2420 . 222 Dacey MJ . Hypomagnesemic disorders . Crit Care Clin 2001 ; 17 ( 1 ): 155 – 173 . 223 Marino P . Magnesium: the hidden ion . In: Marino P , ed. The ICU ook . Philadelphia : Lea & Febiger , 1991 : 489 . 224 Ryan MP . Diuretics and potassium/magnesium depletion . Direction Am J Med 1987 ; 82 : 38A . 225 Zaloga GP , Chernow B , Pock A et al. Hypomagnesemia is a common complication of aminoglycoside therapy . Surg Gynecol Obstet 1984 ; 158 : 561 – 565 . 226 Elin RJ . Magnesium metabolism in health and disease . Dis Mon 1988 ; 34 : 161 – 218 . 227 Berkelhammer C , Bear RA . A clinical approach to common electro- lyte problems: hypomagnesemia . Can Med Assoc J 1985 ; 132 : 360 – 368 . 228 Brauthbar N , Massry SG . Hypomagnesemia and hypermagnesemia . In: Maxwell MH , Kleeman CR , Narins RG , eds. Clinical Disorders of Fluid and Electrolyte Metabolism , 4th edn . New York : McGraw - Hill , 1987 : 831 . 229 Kingston ME , Al - Siba ’ i MB , Skooge WC . Clinical manifestations of hypomagnesemia . Crit Care Med 1986 ; 14 : 950 – 954 . 230 Zaloga GP . Interpretation of the serum magnesium level . Chest 1989 ; 95 : 257 – 258 . 93 Critical Care Obstetrics, 5th edition. Edited by M. Belfort, G. Saade, M. Foley, J. Phelan and G. Dildy. © 2010 Blackwell Publishing Ltd. 7 Cardiopulmonary Resuscitation in Pregnancy Andrea Shields 1 & M. Bardett Fausett 2 1 Antenatal Diagnostic Center, San Antonio Military Medical Center, Lackland Airforce Base, Texas, USA 2 Obstetrics and Maternal - Fetal Medicine, San Antonio Military Medical Center and Department of Obstetrics and Gynecology, Wilford Hall Medical Center, Lackland Airforce Base, Texas, USA Introduction Sudden cardiac arrest (SCA) is a leading cause of death in the United States and Canada. An estimated 330 000 people die annu- ally in the United States from SCA in out - of - hospital and emer- gency department settings [1] . This translates to 0.55 per thousand people in the US, and 1 in 30 000 gravid women who will suffer SCA each year. Overall maternal mortality is signifi cantly higher in developing countries including mortality from SCA. Women of childbearing age are commonly healthy and the overall risk of death is low in developed nations. These facts, along with the additional life involved, make SCA in pregnancy unexpected and particularly devastating. Women are most likely to survive cardiopulmonary arrest when attended by providers skilled in basic and advanced cardio- pulmonary resuscitative techniques. The mechanical and physi- ologic changes of pregnancy impact every phase of the resuscitation process. In this chapter, we review the most recent American Heart Association (AHA) cardiopulmonary resuscitation (CPR) guidelines and emphasize pregnancy - specifi c modifi cations. We do not address infant and child resuscitation in this chapter but the practicing obstetrician should likewise be expert with neona- tal resuscitation. In this chapter, we will consider other relevant pregnancy - related issues such as perimortem cesarean section and the ethical dilemma of prolonged maternal life support for fetal maturation. The initial objective of CPR and emergency cardiac care (ECC) is to maintain adequate oxygenation and vital organ perfusion. CPR restores hemodynamic stability in 40 – 60% of arrested patients; however, prolonged survival is lower with underlying illness [2] . Overall outcome, particularly full neurologic recovery, is improved by early initiation of CPR and defi brillation. Most victims of SCA demonstrate ventricular fi brillation at some point leading to full arrest. Ventricular fi brillation is best treated by electrical cardioversion performed within the fi rst 5 minutes after collapse [3] . Since the majority of SCA occurs outside of the hospital setting, it is uncommon for emergency medical service personnel to be contacted and arrive at the victim ’ s side within these critical 5 minutes [4] . Thus, achieving a high survival rate depends upon public training in CPR and well - organized public access defi brillation programs. Considering all victims, out - of - hospital survival rates for SCA victims are only 6% but can improve to 75% when victims are given high - quality CPR [4] . Outside of the hospital, SCA is usually associated with cata- strophic trauma and is rarely a survivable event for pregnant women even in developed countries. In the hospital, SCA in pregnancy is usually associated with peripartum events [5] . In such circumstances delivery of high - quality CPR is likely to have a signifi cant impact on survival rates. Thus, hospital personnel involved in the care of pregnant women should be expertly trained and facile in techniques of cardiopulmonary resuscitation. Obstetrical units should have proper resuscitative equipment readily available and staff members be engaged in ongoing programs to train and maintain CPR competency. In one recent evaluation of obstetric training programs, the authors concluded that even basic life support knowledge and skills are inadequate and ongoing training is necessary [6] . Current c ardiac c are r ecommendations In December 2005, the American Heart Association published an update to the guidelines for lay and professional Basic and Advanced Cardiac Life Support (BLS/ACLS). A summary of the ABCDs of lay and provider rescuer BLS is shown in Table 7.1 . The primary changes to the 2005 resuscitation guidelines were meant to simplify algorithms and promote their early application to SCA victims. The new guidelines include four major changes relevant to women of reproductive age and are applicable to both lay and provider rescuer CPR [7] . These general changes are sum- marized in Table 7.2 . Chapter 7 94 Airway Head tilt/chin lift unless trauma then use jaw thrust Breathing : Initial 2 breaths at 1 second/breath Rescue breathing without chest compressions 10 – 12 breaths/min Rescue breaths with advanced airway 8 – 10 breaths/min Foreign body obstruction Abdominal thrusts Circulation Pulse check ( ≤ 10 s) Carotid Compression landmarks Lower half of sternum, between nipples Compression method Heel of one hand with the other on top; push hard and fast and allow complete recoil Compression depth 1 ½ to 2 inches Compression rate 100/min Compression : ventilation ratio 30 : 2 (either one or two rescuers) Defi brillation AED After 5 cycles of CPR if out of hospital Table 7.1 Summary of CPR ABCD s (modifi ed from “ Summary of BLS ABCD maneuvers for infants, children and adults ” ) [68] . Table 7.2 Summary of key changes in 2005 CPR guidelines [4] . Deliver more effective chest compressions Early, consistent, fast, hard Single compression : ventilation ratio for all but neonates 30 : 2 Rescue breaths Given over 1 second; 500 – 600 mL for adults Defi brillation After fi rst shock go directly to compression : ventilations × 2 min First, there is signifi cant emphasis on, and recommendations to improve, delivery of effective chest compressions. The key words are early, consistent, fast and hard. This emphasis is made because half of chest compressions (even by healthcare providers) are too shallow. The chest is often not allowed to recoil ade- quately between compressions and interruptions are too common. Complete chest wall recoil increases cardiac fi lling by increasing negative pressure, promoting venous return and maximizing cardiac output with the subsequent compression. The fi rst few compressions after interruption are not as effective as those that follow. Thus, inadequate compressions, incomplete chest recoil and frequent interruptions all signifi cantly decrease circulation and oxygen delivery and decrease survival [7] . The second new recommendation is for a single 30 : 2 compres- sion to ventilation ratio for all victims except newborns. The guideline authors note most cases of cardiac arrest in adults are not hypoxia - induced. Consequently, circulation is more critical than ventilation in the fi rst minute of CPR. Since the blood fl ow to the lungs is diminished (25 – 33%) during arrest/CPR, victims need less ventilation than normal. In contrast, newborn cardiac arrest is commonly related to hypoxia so more ventilations (5:1) to compressions are indicated and remain part of the new guide- lines [7] . The third recommendation is that each rescue breath should be given over 1 second (rather than 1 – 2 seconds) and produces a visible chest rise. The visible chest rise ensures effi cacy and the 1 - second breath provides adequate tidal volume (500 – 600 mL) while avoiding hyperinfl ation. Rescuers are to take a normal breath before giving the rescue breath. Frequent rescue breathing interrupts and delays chest compressions. Hyperinfl ation increases intrathoracic pressure leading to decreased blood return to the chest. This results in diminished effi cacy of the next several compressions and increases the risk of gastric insuffl ation. The fi nal new major recommendation is that during ventricu- lar fi brillation (VF) cardiac arrest, a single shock should be given followed by immediate CPR. CPR is to begin even before the fi rst rhythm check 2 minutes later. Historically, rhythm analysis by automated defi brillators available before 2005 resulted in delays of more than 30 seconds before giving the fi rst post - shock com- pressions. Current defi brillators eliminate VF more than 85% of the time. Thus, in a case where the fi rst shock fails, CPR is likely to convey greater value than a second shock. Even when a shock eliminates VF, it usually takes several minutes for a normal effec- tive rhythm to return. A brief period of CPR can increase energy and oxygen to the heart, increasing the likelihood that the heart will be able to continue effective blood fl ow. There is no evidence that postdefi brillation chest compressions provoke recurrent VF. For similar reasons, lay rescuer CPR recommendations now eliminate the initial check for pulse after giving the initial two rescue breaths [7] . Key changes to recommendations for provider - level and hos- pital - based adult BLS include use of the 30 : 2 ventilation to com- pression ratio (even with two rescuers) until an advanced airway is in place. As noted in the general guidelines above, before an advanced airway is in place, rescuers should perform 5 cycles of CPR after shock before the next rhythm check. Even once the advanced airway is in place, rescuers should perform 2 minutes Cardiopulmonary Resuscitation in Pregnancy 95 of CPR after shock before the next rhythm check. With two or more rescuers and an advanced airway in place, rescuers no longer provide cycles of compressions with pauses for ventila- tion. One rescuer provides 8 – 10 breaths per minute (1 every 6 – 8 seconds) while the other rescuer provides continuous compres- sions. Where possible, rescuers should rotate the compressor role every 2 minutes, taking no more than 5 seconds to do so. After 2 – 3 minutes of CPR, rescuers typically perform chest compres- sions less effectively [7] . The general provider BLS algorithm is shown in Figure 7.1 and the pulseless arrest ACLS algorithm in Figure 7.2 . Algorithms for tachycardia and bradycardia are not included here but are usually available on all “ code carts ” . Patient p opulation and e tiologies of SCA in p regnancy Of women who suffer SCA during pregnancy, most have throm- boembolic - , followed by hemorrhage - , related events [8] . The most common causes of SCA during pregnancy are listed in Table 7.3 . Victims of SCA in pregnancy are younger and have fewer underlying medical conditions than non - pregnant victims [8] . However, maternal age and underlying medical problems con- tinue to increase in developed countries due to elective delayed childbearing and advanced reproductive technologies. Pregnancy increases the risk of venous thromboembolic disease (VTE) due to hormonally stimulated increases of virtually all of the procoagulant proteins. The risk of VTE is amplifi ed by condi- tions necessitating bed rest such as gestational hypertensive dis- orders and preterm labor. The risk is highest in the immediate postpartum period, [9] probably due to the tissue trauma and decreased physical activity associated with delivery. Lipo - oxidative injury to the coronary vessels is the most common cause of SCA in non - pregnant individuals but is an uncommon cause of SCA in pregnancy. However, the added physiologic stress of pregnancy can unveil underlying congenital or acquired valve disease. Pregnancy does increase the risk of myocardial infarction 3 – 4 - fold over otherwise comparable non - pregnant women. The pregnancy - related MI risk is signifi cantly greater in women older than 30 years [10] . Additionally, pregnant women have a relatively increased risk of coronary artery and aortic dissections compared to non - pregnant women with other- wise similar demographic characteristics [11] . This may be due to progesterone - mediated relaxation of smooth muscle. Pregnancy - s pecifi c c onditions a ssociated with SCA Turning now to pregnancy - specifi c conditions associated with SCA, we fi rst highlight the anaphylactoid syndrome of pregnancy also called amniotic fl uid embolus (AFE). This disorder is char- acterized by an anaphylaxis - like syndrome that is associated with cardiac depression, cardiopulmonary collapse and coagulopathy. The disorder is highly lethal with a 50 – 65% risk of cardiac arrest and maternal death [12 – 15] . This catastrophic condition is discussed in detail in Chapter 35 but the reader is encouraged to remember that this disorder is associated with profound vascular leak, and over - resuscitation with crystalloid fl uids can result in massive pulmonary edema. Therapy targeted to support the cardiovascular system and correct the coagulopathy while avoiding over - resuscitation with crystalloid fl uid may be helpful [16] . Gestational hypertensive disorders occur more frequently than thromboembolic disorders and both occur more commonly than anaphylactoid syndrome of pregnancy [14] . Women with hyper- tensive disorders of pregnancy are at increased risk of SCA for several reasons including the associated underlying endothelial injury and infl ammatory response. Hypertension may necessitate medical therapy and magnesium is often used for seizure prophy- laxis. Both may be associated with cardiac compromise leading to SCA [17 – 20] . Profound hypotension and SCA can occur in women with pre - eclampsia treated concurrently with calcium channel antagonists and magnesium sulfate. In cases of cardio- pulmonary compromise due to magnesium sulfate toxicity, resuscitation must include calcium rescue. The typical dose is 1 g of intravenous calcium carbonate. ABCD s in p regnancy If breathing stops fi rst, then the heart often continues to pump for several minutes usually providing enough oxygen in the lungs and bloodstream to support life for up to 6 minutes [21] . In contrast, when the heart stops fi rst, oxygen in the lungs and bloodstream cannot be circulated to vital organs. The patient whose heart and respirations have stopped for less than 4 minutes has an excellent chance of recovery if CPR is administered imme- diately and is followed by ACLS within 4 minutes [22] . By 4 – 6 minutes, brain damage may occur, and after 6 minutes, brain damage will almost always occur. Therefore, the initial goals of CPR are to deliver oxygen to the lungs and provide a means of circulation to the vital organs. Initially circulation is provided via closed - chest compression followed by ACLS, with restoration of the heart as the mechanism of circulation. These goals are achieved by remembering the “ ABCDs ” of the primary and sec- ondary survey (Table 7.1 ). The primary survey consists of airway management using non - invasive techniques, breathing with pos- itive - pressure ventilations, and performing CPR until equipment for external defi brillation arrives. Out - of - hospital and BLS tools required include gloved hands, a barrier device for CPR, and an automated external defi brillator (AED) for defi brillation. A sec- ondary survey requires the use of advanced, invasive techniques as the rescuer attempts to resuscitate, stabilize, and transfer the patient to a higher level of care if indicated (i.e. hospital or inten- sive care setting). Potentially reversible causes of cardiopulmo- nary arrest should also be considered and addressed at this stage (Table 7.4 ). Chapter 7 96 If not breathing, give 2 BREATHS that make chest rise Denite Pulse Shockable Not Shockable If no response, check pulse: Do you DEFINITELY feel pulse within 10 seconds? No movement or response PHONE 911 or emergency number Get AED or send second rescuer (if available) to do this Open AIR WAY, check BREATHING Resume CPR immediately for 5 cycles Check rhythm every 5 cycles; continue until ALS providers take over or victim starts to move Give cycles of 30 COMPRESSIONS and 2 BREATHS until AED/debrillator arrives, ALS providers take over, or victim starts to move Push hard and fast (100/min) and release completely Minimize interruptions in compressions AED/debrillator ARRIVES Check Rhythm Shockable rhythm? Give 1 shock Resume CPR immediately for 5 cycles -Give 1 breath every 5 to 6 seconds -Recheck pulse every 2 minutes 5A 1 2 3 4 5 6 7 8 910 No Pulse Figure 7.1 ACLS Adult BLS Provider Algorithm. Modifi ed from Circulation 2005; 112: IV - 58 – IV - 66. Cardiopulmonary Resuscitation in Pregnancy 97 Figure 7.2 ACLS Adult Pulseless Arrest Algorithm. Modifi ed from Circulation 2005; 112: IV - 58 – IV - 66. Shockable Not Shockable Shockable Give 5 cycles of CPR* Give 5 cycles of CPR* Shockable Give 5 cycles of CPR* Not Shockable Shockable Check rhythm Shockable rhythm? PULSELESS ARREST • BLS Algorithm: Call for help, ve CPR • Give oxygen when available • Attach monitor/debrillator when available Continue CPR while debrillator is charging Give 1 shock • Manual biphasic: device specic (typically 120 to 200 J) • AED: device specic • Monophasic: 360 J Resume CPR immediately after the shock When IV/IO available, give vasopressor during CPR (before or after the shock) • Epinephrine 1 mg IV/IO Repeat every 3 to 5 minutes or • May give 1 dose of vasopressin 40 U IV/IO to replace rst or second dose of ephinephrine VF/VT Asystole/PEA Give 1 shock • Manual biphasic: device specic (typically 120 to 200 J) • AED: device specic • Monophasic: 360 J Resume CPR immediately Check rhythm Shockable rhythm? Continue CPR while debrillator is charging Give 1 shock • Manual biphasic: device specic (typically 120 to 200 J) • AED: device specic • Monophasic: 360 J Resume CPR immediately after the shock Consider antiarrhythmics; give during CPR (before or after the shock) amiodarone (300 mg IV/IO once, then consider additional 150 mg IV/IO once) or lidocaine (1 to 1.5 mg/kg rst dose, then 0.5 to 0.75 mg/ kg IV/IO, maximum 3 doses or 3 mg/kg) Consider magnesium, loading dose 1 to 2 g IV/IO for torsades de pointes After 5 cycles of CPR,* go to Box 5 above Check rhythm Shockable rhythm? • If asystole, go to Box 10 • If elecrical activity, check pulse, If no pulse, got to Box 10 • If pulse present, begin postresuscitation care Resume CPR immediately for 5 cycles When IV/IO available, give vasopressor • Epinephrine 1 mg IV/IO Repeat every 3 to 5 minutes or • May give 1 dose of vasopressin 40 U IV/IO to replace rst or second dose of ephinephrine Consider atropine 1 mg IV/IO for asystole or slow PEA rate Repeat every 3 to 5 min (up to 3 doses) Check rhythm Shockable rhythm? Go to Box 4 During CPR • Push hard and fast (100/min) • Ensure full chest recoil • Minimize interruptions in chest compressions • One cycle of CPR; 30 compressions then 2 breaths; 5 cycles takes about 2 min •Avoid hyperventilation • Secure airway and conrm placement After an advanced airway is placed, rescuers no longer deliver “cycles” of CPR, Give continuous chest com- pressions with pauses for breaths. Give 8 to 10 breaths/minute. Check rhythm every 2 minutes • Rotate compressors every 2 minutes with rhythm checks • Search for and treat possible contributing factors: •Hypovolemia •Hypoxia •Hydogen ion (acidosis) •Hypo-/hyperkalemia •Hypoglycemia •Hypothermia •Toxins •Tamponade, cardiac •Tension pneumothorax •Thrombosis (coronary or pulmonary) •Trauma No No 1 2 3 4 5 6 7 8 9 10 11 12 13 Airway Delivery of oxygen is achieved by positioning the patient, opening the airway, and delivering rescue breaths. In the absence of muscle tone, the tongue and epiglottis frequently obstruct the airway. The head tilt with the chin - lift maneuver (Figure 7.3 ) or the jaw thrust maneuver (Figure 7.4 ) facilitates airway access. If foreign material appears in the mouth, it should be removed. If air does not enter the lungs with rescue breathing, reposition the head and repeat the attempt at rescue breathing. Persistent obstruction may require the Heimlich maneuver (subdiaphrag- matic abdominal thrusts), chest thrusts, removal of foreign body if now visualized, and rescue breathing. The Heimlich maneuver cannot be used in the late stages of pregnancy or in the obese choking victim. Airway obstruction may occur in a choking victim as well as the patient experiencing a cardiopulmonary arrest. The conscious women with only partial airway obstruction should be allowed to attempt to clear the obstruction herself. Rescuers should avoid the fi nger sweep in a conscious patient. In the fi rst half of pregnancy, airway obstruction can be relieved with the Heimlich maneuver or abdominal thrusts. From a stand- ing position the rescuer wraps his arms around the victim ’ s waist, making a fi st with one hand and placing the thumb side of the fi st against the victim ’ s abdomen in the midline slightly above the umbilicus and well below the top of the xiphoid process. The rescuer grasps the fi st with the other hand and presses the fi st into the victim ’ s abdomen with quick, distinct, upward thrusts. The thrusts are continued until the object is expelled or the victim is unconscious. The unconscious victim is placed supine, the heel of one hand remains against the victim ’ s abdomen, in the midline slightly above the umbilicus but below the top of the xiphoid. The Chapter 7 98 second hand lies directly on top of the fi rst, and quick upward thrusts are administered. In the latter half of pregnancy, the gravid uterus or maternal habitus may necessitate the use of chest thrusts instead of abdom- inal thrusts. Chest thrusts in a conscious sitting or standing victim require placing the thumb side of the fi st on the middle of the sternum, avoiding the xiphoid and the ribs. The rescuer then grabs his or her own fi st with the other hand and performs chest thrusts until either the foreign object is dislodged or the patient loses consciousness. The unconscious patient is placed supine. The rescuer ’ s hand closest to the patient ’ s head is placed 2 fi nger- breadths above the xiphoid. The long axis of the heel of the provider ’ s hand rests on the long axis of the sternum and the other hand lies over the fi rst, with the fi ngers either extended or interlaced. The elbows are extended and the chest is compressed 1.5 – 2 inches. Up to 5 abdominal or chest thrusts are given fol- lowed by repetition of the jaw - lift, foreign body visualization, and attempted ventilation. These steps are repeated until effective or until a surgical airway can be obtained by emergency cricothy- rotomy or jet - needle insuffl ation. If, after clearing any obstruction, the patient is unresponsive but breathing spontaneously, she is placed in the recovery posi- tion to keep the airway open. The pregnant victim is placed on her left side. The left arm is placed at a right angle to the victim ’ s torso, while the right arm is placed across her chest with the back of her hand under the lower cheek. The victim ’ s right thigh is fl exed at a right angle to the torso, across the left leg, with the right knee resting on the surface. The victim ’ s head is tilted back to maintain the airway, using the right hand to maintain the head tilt. Fetal monitoring should begin as soon as possible and breath- ing is monitored regularly. If breathing does not resume after clearing the airway or if it stops, the emergency medical system is activated and the BCDs of CPR continued. Table 7.3 Causes of cardiac arrest during pregnancy [69] . Venous thromboembolism Pregnancy - induced hypertension Sepsis Amniotic fl uid embolism Hemorrhage Placental abruption Placenta previa Uterine atony Disseminated intravascular coagulation Trauma Iatrogenic Medication errors or allergy Anesthetic complications Hypermagnesemia Pre - existing heart disease Congenital Acquired Table 7.4 Potentially reversible causes of cardiac arrest. Hypovolemia Hypoxia Hydrogen ion acidosis Hyper - or hypokalemia, other metabolic Hypothermia Tablets (drug overdose) Trauma Tamponade, cardiac Tension pneumothorax Thrombosis, coronary Thrombosis, pulmonary Toxins (e.g. amniotic fl uid) Figure 7.3 Head tilt, chin lift. Figure 7.4 Jaw thrust. . hyper- phosphatemia: a metabolic consideration in critical care medicine . Crit Care Med 1981 ; 9 : 772 – 774 . 205 Zaloga GP . Phosphate disorders . Probl Crit Care 1990 ; 4 : 416 . 206 Nagant De. hypomagnesemia . Crit Care Med 1986 ; 14 : 950 – 954 . 230 Zaloga GP . Interpretation of the serum magnesium level . Chest 1989 ; 95 : 257 – 258 . 93 Critical Care Obstetrics, 5th edition : 228 – 230 . 110 Maurer PH , Berardinelli B . Immunologic studies with hydroxyethyl starch (HES): a proposed plasma expander . Transfusion 1968 ; 8 : 265 – 268 . 111 Ring J , Seifert

Ngày đăng: 05/07/2014, 16:20

Từ khóa liên quan

Tài liệu cùng người dùng

  • Đang cập nhật ...

Tài liệu liên quan